ORPP logo
Image from Google Jackets

Cancer Consult : Expertise for Clinical Practice.

By: Contributor(s): Material type: TextTextPublisher: Newark : John Wiley & Sons, Incorporated, 2014Copyright date: ©2014Edition: 1st edDescription: 1 online resource (1804 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781118589175
Subject(s): Genre/Form: Additional physical formats: Print version:: Cancer ConsultLOC classification:
  • RC261 -- .C363 2014eb
Online resources:
Contents:
Intro -- Table of Contents -- Dedication -- Title page -- Copyright page -- List of Contributors -- Preface -- SECTION 1: Malignant Hematology and Hematopoietic Cell Transplantation -- PART 1: Acute Lymphoblastic Leukemia in Adults -- CHAPTER 1: Diagnosis of Acute Lymphoblastic Leukemia -- Case Study Answers -- Selected Readings -- CHAPTER 2: Prognostic Markers and Models in Acute Lymphoblastic Leukemia -- Pretherapeutic Prognostic Markers -- Response Parameters -- Stratification into Risk Groups -- Selected Reading -- CHAPTER 3: Management of B-Cell Acute Lymphoblastic Leukemia -- Selected Reading -- CHAPTER 4: Management of T-Cell Acute Lymphoblastic Leukemia -- Selected Reading -- CHAPTER 5: Minimal Residual Disease in Acute Lymphoblastic Leukemia -- Case Study Answers -- Selected Reading -- CHAPTER 6: Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia -- Multiple Choice and Discussion Questions -- Mutiple Choice Answer -- Case Study Answer -- Selected Reading -- PART 2: Acute Myeloid Leukemia in Adults -- CHAPTER 7: Prognosis in Acute Myeloid Leukemia: Cytogenetics and Beyond -- Case Study Answers -- Selected Reading -- CHAPTER 8: Induction Therapy in Acute Myeloid Leukemia -- Case Study Answers -- Selected Reading -- CHAPTER 9: Consolidation Therapy in Acute Myeloid Leukemia -- Selected Reading -- CHAPTER 10: Management of Acute Promyelocytic Leukemia -- Selected Reading -- CHAPTER 11: Minimal Residual Disease in Acute Myeloid Leukemia -- Selected Reading -- CHAPTER 12: Relapsed and Refractory Acute Myeloid Leukemia -- Multiple Choice Questions -- Case Study Answers -- Mutiple Choise Answers -- Selected Reading -- CHAPTER 13: Hematopoietic Cell Transplantation in Acute Myeloid Leukemia -- Multiple choice question -- Case Study Answers -- Mutiple choice answer -- Selected reading.
PART 3: Myelodysplastic Syndromes and Related Disorders -- CHAPTER 14: Pitfalls in the Diagnosis of Myelodysplastic Syndromes -- Case Study Answers -- Selected Reading -- CHAPTER 15: Cytogenetics and Prognostic Models in Myelodysplastic Syndromes -- MDS Cytogenetics and Prognosis -- Conclusion -- Selected Reading -- CHAPTER 16: Management of Myelodysplastic Syndromes -- Selected Reading -- CHAPTER 17: Management of Therapy-Related Myeloid Neoplasms -- Introduction -- Multiple Choice Questions -- Multiple Choice Answers -- Note -- Selected Reading -- CHAPTER 18: Hematopoietic Cell Transplantation in Myelodysplastic Syndromes -- Notes -- Selected Reading -- CHAPTER 19: Acquired Aplastic Anemia -- Case Study Answers -- Selected Reading -- PART 4: Myeloproliferative Neoplasms -- CHAPTER 20: Diagnostic Approach in Myeloproliferative Neoplasms -- Introduction -- Selected Reading -- CHAPTER 21: Chronic Myeloid Leukemia: Chronic Phase -- Introduction -- Multiple Choice and Discussion Questions -- Multiple Choice Answer -- Selected Reading -- Selected Websites -- CHAPTER 22: Blast Crisis of Chronic Myeloid Leukemia -- Selected Reading -- CHAPTER 23: Chronic Myeloid Leukemia and Pregnancy -- Selected Reading -- CHAPTER 24: Polycythemia Vera -- Selected Reading -- CHAPTER 25: Essential Thrombocytosis -- Note -- Case Study Answers -- Selected Reading -- CHAPTER 26: Primary Myelofibrosis -- Introduction -- Selected Reading -- CHAPTER 27: Eosinophilic Myeloproliferative Disorders -- Case Study Answers -- Selected Reading -- CHAPTER 28: Chronic Myelomonocytic Leukemia -- Selected Reading -- CHAPTER 29: Hematopoietic Cell Transplantation in Chronic Myeloid Leukemia -- Case Study Answers -- Selected Reading -- CHAPTER 30: Hematopoietic Cell Transplantation in Primary Myelofibrosis -- Conclusion -- Selected Reading -- PART 5: Chronic Lymphocytic and Other Leukemias.
CHAPTER 31: Prognostic Markers and Management of Chronic Lymphocytic Leukemia -- Multiple Choice Questions -- Multiple Choice Answers -- Selected reading -- CHAPTER 32: Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia -- Selected Reading -- CHAPTER 33: Prolymphocytic Leukemia -- Summary -- Case Study Answers -- Selected Reading -- CHAPTER 34: Hairy Cell Leukemia -- Multiple Choice and Discussion Questions -- Selected Reading -- Case Study Answers -- Multiple Choice Answer -- PART 6: Hodgkin Lymphoma -- CHAPTER 35: Management of Classical Hodgkin Lymphoma -- Case Study Answers -- Selected Reading -- CHAPTER 36: Nodular Lymphocyte-Predominant Hodgkin Lymphoma -- Multiple Choice Questions -- Multiple Choice Answers -- Seleced Reading -- CHAPTER 37: Hematopoietic Cell Transplantation in Hodgkin Lymphoma -- Selected Reading -- PART 7: Non-Hodgkin's Lymphomas -- CHAPTER 38: Pitfalls in the Diagnosis of Non-Hodgkin's Lymphomas -- Case Study Answers -- Selected Reading -- CHAPTER 39: Follicular Lymphoma -- Case Study Answers -- Selected Reading -- CHAPTER 40: Diffuse Large B-Cell Lymphoma -- Introduction -- Multiple Choice and Discussion Questions -- Conclusion -- Multiple Choice Answers -- Selected Reading -- CHAPTER 41: Mantle Cell Lymphoma -- Case Study Answers -- Selected Reading -- CHAPTER 42: Marginal Zone Lymphoma -- Treatment Controversies -- Selected Reading -- CHAPTER 43: Primary Mediastinal Large B-Cell Lymphoma -- Clinical Features -- Primary Management -- Selected reading -- CHAPTER 44: Burkitt Lymphoma -- Selected Reading -- CHAPTER 45: Gray Zone Lymphoma -- Selected Reading -- CHAPTER 46: Transformed Lymphoma -- Multiple Choice Question -- Multiple Choice Question -- Case Study Answers -- Multiple Choice Answers -- Selected Reading -- CHAPTER 47: HIV-Associated Lymphoma -- Selected Reading -- CHAPTER 48: Primary CNS Lymphoma.
Case Study Answers -- Selected Reading -- CHAPTER 49: Primary Cutaneous Lymphoma -- Introduction -- Topical Approaches -- Ultraviolet B Phototherapy and Ultraviolet A Photochemotherapy -- Total Skin Electron Beam Therapy -- Treatment of Advanced-Stage Disease -- Extracorporeal Photochemotherapy -- Recombinant Interferon -- Bexarotene -- Denileukin Difitox -- Histone Deacetylase (HDAC) Inhibitors -- Purine Nucleoside Analogs -- Pegylated Liposomal Doxorubicin -- Pralatrexate -- Monoclonal Antibodies -- Combined-Modality Systemic Chemotherapy -- High-Dose Chemotherapy and Hematopoietic Stem Cell Transplantation -- Treatment Summary -- Survivorship Issues in Cutaneous T-Cell Lymphoma -- Conclusion -- Suggested Reading -- CHAPTER 50: Mycosis Fungoides and Sézary Syndrome -- Selected Reading -- CHAPTER 51: Hematopoietic Cell Transplantation in Indolent Non-Hodgkin's Lymphoma -- Selected Reading -- CHAPTER 52: Hematopoietic Cell Transplantation in Diffuse Large B-cell Lymphoma -- Case Study Answers -- Selected Reading -- CHAPTER 53: Hematopoietic Cell Transplantation in T-Cell Non-Hodgkin's Lymphomas -- Introduction -- Summary -- Selected Reading -- PART 8: Plasma Cell Neoplasms and Related Disorders -- CHAPTER 54: Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance -- Mutiple Choice and Discussion Questions -- Smoldering (Asymptomatic) Multiple Myeloma (SMM) -- Mutiple Choice Answers -- Selected Reading -- CHAPTER 55: Risk Stratification and Response Assessment in Multiple Myeloma and Waldenström's Macroglobulinemia -- Case Study Answers -- Selected Reading -- CHAPTER 56: Treatment of Multiple Myeloma -- Prognostic Markers -- Mutiple Choice Questions -- Front-Line Therapy in Symptomatic Multiple Myeloma -- Treatment Strategies -- Case Study Answers -- Mutiple Choice Ansewrs -- Selected Reading.
CHAPTER 57: Light-Chain Amyloidosis -- Case Study Answers -- Selected Reading -- CHAPTER 58: Waldenström's Macroglobulinemia -- Mutiple Choice and Discussion Questions -- Cryoglobulinemia and Related Autoimmune Disorders in WM -- Risk of Amyloid Light-Chain (AL) Amyloidosis -- IgM-Related Neurologic Manifestations -- Survivorship Issues in W4M -- Mutiple Choice Answer -- Case Study Answers -- Selected Reading -- CHAPTER 59: Autologous Hematopoietic Cell Transplantation in Multiple Myeloma -- Selected Reading -- CHAPTER 60: Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma -- Introduction -- The Evolution of the Allogeneic Approach in MM -- Randomized Trials -- Lenalidomide -- Bortezomib -- Measuring the Efficacy of Allo-HCT and Defining Deeper Remissions After Allo-HCT -- The Future of Allo-HCT for MM -- Selected Reading -- PART 9: Special Issues in Hematology -- CHAPTER 61: Role of PET Scan in Lymphomas -- Mutiple Choice Questions -- Case Study Answers -- Multiple Choice Answers -- Selected Reading -- CHAPTER 62: Radioimmunotherapy in Lymphomas -- Multiple Choice Questions -- Mutiple Choice Answers -- Selected Reading -- CHAPTER 63: Radiation Oncology Consultation for Hematologic Malignancies -- Selected Reading -- PART 10: Special Issues in Hematopoietic Cell Transplantation -- CHAPTER 64: Donor and Graft Selection in Allogeneic Hematopoietic Cell Transplantation -- Introduction -- Case Study Answers -- Selected Reading -- CHAPTER 65: Preparative Regimens in Allogeneic Hematopoietic Cell Transplantation for Malignant Hematological Diseases -- Multiple Choice Questions -- Multiple Choice Answers -- Selected Reading -- CHAPTER 66: T-Cell Depletion in Allogeneic Hematopoietic Cell Transplantation -- Introduction -- Conclusions -- Selected Reading.
CHAPTER 67: Prevention and Treatment of Relapse Following Hematopoietic Cell Transplantation.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Intro -- Table of Contents -- Dedication -- Title page -- Copyright page -- List of Contributors -- Preface -- SECTION 1: Malignant Hematology and Hematopoietic Cell Transplantation -- PART 1: Acute Lymphoblastic Leukemia in Adults -- CHAPTER 1: Diagnosis of Acute Lymphoblastic Leukemia -- Case Study Answers -- Selected Readings -- CHAPTER 2: Prognostic Markers and Models in Acute Lymphoblastic Leukemia -- Pretherapeutic Prognostic Markers -- Response Parameters -- Stratification into Risk Groups -- Selected Reading -- CHAPTER 3: Management of B-Cell Acute Lymphoblastic Leukemia -- Selected Reading -- CHAPTER 4: Management of T-Cell Acute Lymphoblastic Leukemia -- Selected Reading -- CHAPTER 5: Minimal Residual Disease in Acute Lymphoblastic Leukemia -- Case Study Answers -- Selected Reading -- CHAPTER 6: Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia -- Multiple Choice and Discussion Questions -- Mutiple Choice Answer -- Case Study Answer -- Selected Reading -- PART 2: Acute Myeloid Leukemia in Adults -- CHAPTER 7: Prognosis in Acute Myeloid Leukemia: Cytogenetics and Beyond -- Case Study Answers -- Selected Reading -- CHAPTER 8: Induction Therapy in Acute Myeloid Leukemia -- Case Study Answers -- Selected Reading -- CHAPTER 9: Consolidation Therapy in Acute Myeloid Leukemia -- Selected Reading -- CHAPTER 10: Management of Acute Promyelocytic Leukemia -- Selected Reading -- CHAPTER 11: Minimal Residual Disease in Acute Myeloid Leukemia -- Selected Reading -- CHAPTER 12: Relapsed and Refractory Acute Myeloid Leukemia -- Multiple Choice Questions -- Case Study Answers -- Mutiple Choise Answers -- Selected Reading -- CHAPTER 13: Hematopoietic Cell Transplantation in Acute Myeloid Leukemia -- Multiple choice question -- Case Study Answers -- Mutiple choice answer -- Selected reading.

PART 3: Myelodysplastic Syndromes and Related Disorders -- CHAPTER 14: Pitfalls in the Diagnosis of Myelodysplastic Syndromes -- Case Study Answers -- Selected Reading -- CHAPTER 15: Cytogenetics and Prognostic Models in Myelodysplastic Syndromes -- MDS Cytogenetics and Prognosis -- Conclusion -- Selected Reading -- CHAPTER 16: Management of Myelodysplastic Syndromes -- Selected Reading -- CHAPTER 17: Management of Therapy-Related Myeloid Neoplasms -- Introduction -- Multiple Choice Questions -- Multiple Choice Answers -- Note -- Selected Reading -- CHAPTER 18: Hematopoietic Cell Transplantation in Myelodysplastic Syndromes -- Notes -- Selected Reading -- CHAPTER 19: Acquired Aplastic Anemia -- Case Study Answers -- Selected Reading -- PART 4: Myeloproliferative Neoplasms -- CHAPTER 20: Diagnostic Approach in Myeloproliferative Neoplasms -- Introduction -- Selected Reading -- CHAPTER 21: Chronic Myeloid Leukemia: Chronic Phase -- Introduction -- Multiple Choice and Discussion Questions -- Multiple Choice Answer -- Selected Reading -- Selected Websites -- CHAPTER 22: Blast Crisis of Chronic Myeloid Leukemia -- Selected Reading -- CHAPTER 23: Chronic Myeloid Leukemia and Pregnancy -- Selected Reading -- CHAPTER 24: Polycythemia Vera -- Selected Reading -- CHAPTER 25: Essential Thrombocytosis -- Note -- Case Study Answers -- Selected Reading -- CHAPTER 26: Primary Myelofibrosis -- Introduction -- Selected Reading -- CHAPTER 27: Eosinophilic Myeloproliferative Disorders -- Case Study Answers -- Selected Reading -- CHAPTER 28: Chronic Myelomonocytic Leukemia -- Selected Reading -- CHAPTER 29: Hematopoietic Cell Transplantation in Chronic Myeloid Leukemia -- Case Study Answers -- Selected Reading -- CHAPTER 30: Hematopoietic Cell Transplantation in Primary Myelofibrosis -- Conclusion -- Selected Reading -- PART 5: Chronic Lymphocytic and Other Leukemias.

CHAPTER 31: Prognostic Markers and Management of Chronic Lymphocytic Leukemia -- Multiple Choice Questions -- Multiple Choice Answers -- Selected reading -- CHAPTER 32: Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia -- Selected Reading -- CHAPTER 33: Prolymphocytic Leukemia -- Summary -- Case Study Answers -- Selected Reading -- CHAPTER 34: Hairy Cell Leukemia -- Multiple Choice and Discussion Questions -- Selected Reading -- Case Study Answers -- Multiple Choice Answer -- PART 6: Hodgkin Lymphoma -- CHAPTER 35: Management of Classical Hodgkin Lymphoma -- Case Study Answers -- Selected Reading -- CHAPTER 36: Nodular Lymphocyte-Predominant Hodgkin Lymphoma -- Multiple Choice Questions -- Multiple Choice Answers -- Seleced Reading -- CHAPTER 37: Hematopoietic Cell Transplantation in Hodgkin Lymphoma -- Selected Reading -- PART 7: Non-Hodgkin's Lymphomas -- CHAPTER 38: Pitfalls in the Diagnosis of Non-Hodgkin's Lymphomas -- Case Study Answers -- Selected Reading -- CHAPTER 39: Follicular Lymphoma -- Case Study Answers -- Selected Reading -- CHAPTER 40: Diffuse Large B-Cell Lymphoma -- Introduction -- Multiple Choice and Discussion Questions -- Conclusion -- Multiple Choice Answers -- Selected Reading -- CHAPTER 41: Mantle Cell Lymphoma -- Case Study Answers -- Selected Reading -- CHAPTER 42: Marginal Zone Lymphoma -- Treatment Controversies -- Selected Reading -- CHAPTER 43: Primary Mediastinal Large B-Cell Lymphoma -- Clinical Features -- Primary Management -- Selected reading -- CHAPTER 44: Burkitt Lymphoma -- Selected Reading -- CHAPTER 45: Gray Zone Lymphoma -- Selected Reading -- CHAPTER 46: Transformed Lymphoma -- Multiple Choice Question -- Multiple Choice Question -- Case Study Answers -- Multiple Choice Answers -- Selected Reading -- CHAPTER 47: HIV-Associated Lymphoma -- Selected Reading -- CHAPTER 48: Primary CNS Lymphoma.

Case Study Answers -- Selected Reading -- CHAPTER 49: Primary Cutaneous Lymphoma -- Introduction -- Topical Approaches -- Ultraviolet B Phototherapy and Ultraviolet A Photochemotherapy -- Total Skin Electron Beam Therapy -- Treatment of Advanced-Stage Disease -- Extracorporeal Photochemotherapy -- Recombinant Interferon -- Bexarotene -- Denileukin Difitox -- Histone Deacetylase (HDAC) Inhibitors -- Purine Nucleoside Analogs -- Pegylated Liposomal Doxorubicin -- Pralatrexate -- Monoclonal Antibodies -- Combined-Modality Systemic Chemotherapy -- High-Dose Chemotherapy and Hematopoietic Stem Cell Transplantation -- Treatment Summary -- Survivorship Issues in Cutaneous T-Cell Lymphoma -- Conclusion -- Suggested Reading -- CHAPTER 50: Mycosis Fungoides and Sézary Syndrome -- Selected Reading -- CHAPTER 51: Hematopoietic Cell Transplantation in Indolent Non-Hodgkin's Lymphoma -- Selected Reading -- CHAPTER 52: Hematopoietic Cell Transplantation in Diffuse Large B-cell Lymphoma -- Case Study Answers -- Selected Reading -- CHAPTER 53: Hematopoietic Cell Transplantation in T-Cell Non-Hodgkin's Lymphomas -- Introduction -- Summary -- Selected Reading -- PART 8: Plasma Cell Neoplasms and Related Disorders -- CHAPTER 54: Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance -- Mutiple Choice and Discussion Questions -- Smoldering (Asymptomatic) Multiple Myeloma (SMM) -- Mutiple Choice Answers -- Selected Reading -- CHAPTER 55: Risk Stratification and Response Assessment in Multiple Myeloma and Waldenström's Macroglobulinemia -- Case Study Answers -- Selected Reading -- CHAPTER 56: Treatment of Multiple Myeloma -- Prognostic Markers -- Mutiple Choice Questions -- Front-Line Therapy in Symptomatic Multiple Myeloma -- Treatment Strategies -- Case Study Answers -- Mutiple Choice Ansewrs -- Selected Reading.

CHAPTER 57: Light-Chain Amyloidosis -- Case Study Answers -- Selected Reading -- CHAPTER 58: Waldenström's Macroglobulinemia -- Mutiple Choice and Discussion Questions -- Cryoglobulinemia and Related Autoimmune Disorders in WM -- Risk of Amyloid Light-Chain (AL) Amyloidosis -- IgM-Related Neurologic Manifestations -- Survivorship Issues in W4M -- Mutiple Choice Answer -- Case Study Answers -- Selected Reading -- CHAPTER 59: Autologous Hematopoietic Cell Transplantation in Multiple Myeloma -- Selected Reading -- CHAPTER 60: Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma -- Introduction -- The Evolution of the Allogeneic Approach in MM -- Randomized Trials -- Lenalidomide -- Bortezomib -- Measuring the Efficacy of Allo-HCT and Defining Deeper Remissions After Allo-HCT -- The Future of Allo-HCT for MM -- Selected Reading -- PART 9: Special Issues in Hematology -- CHAPTER 61: Role of PET Scan in Lymphomas -- Mutiple Choice Questions -- Case Study Answers -- Multiple Choice Answers -- Selected Reading -- CHAPTER 62: Radioimmunotherapy in Lymphomas -- Multiple Choice Questions -- Mutiple Choice Answers -- Selected Reading -- CHAPTER 63: Radiation Oncology Consultation for Hematologic Malignancies -- Selected Reading -- PART 10: Special Issues in Hematopoietic Cell Transplantation -- CHAPTER 64: Donor and Graft Selection in Allogeneic Hematopoietic Cell Transplantation -- Introduction -- Case Study Answers -- Selected Reading -- CHAPTER 65: Preparative Regimens in Allogeneic Hematopoietic Cell Transplantation for Malignant Hematological Diseases -- Multiple Choice Questions -- Multiple Choice Answers -- Selected Reading -- CHAPTER 66: T-Cell Depletion in Allogeneic Hematopoietic Cell Transplantation -- Introduction -- Conclusions -- Selected Reading.

CHAPTER 67: Prevention and Treatment of Relapse Following Hematopoietic Cell Transplantation.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.

© 2024 Resource Centre. All rights reserved.